Skip to content

bridgebiowp

Just another WordPress site

Monthly Archives: February 2017

Redirecting N-Acetylaspartate Metabolism in the Central Nervous System Normalizes Myelination and Rescues Canavan Disease

Posted byJulianne TwiningFebruary 9, 2017February 11, 2019Posted inUncategorizedLeave a comment on Redirecting N-Acetylaspartate Metabolism in the Central Nervous System Normalizes Myelination and Rescues Canavan Disease

Recent Posts

  • BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
  • BridgeBio Pharma’s Origin Biosciences Initiates Rolling Submission Of New Drug Application With The U.S. FDA For BBP-870 For The Treatment Of MoCD Type A
  • PellePharm Completes Enrollment of Pivotal Phase 3 Clinical Trial of Patidegib Topical Gel in Patients with Gorlin Syndrome
  • BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
  • BridgeBio and Eidos Present Data from Phase 2 Open Label Extension Suggesting Long-term Tolerability of AG10 and Stabilization of Transthyretin Amyloid Cardiomyopathy Disease Measures

Recent Comments

    Archives

    • December 2019
    • November 2019
    • October 2019
    • September 2019
    • June 2019
    • May 2019
    • February 2019
    • January 2019
    • December 2018
    • November 2018
    • October 2018
    • September 2018
    • August 2018
    • June 2018
    • May 2018
    • April 2018
    • March 2018
    • January 2018
    • November 2017
    • October 2017
    • September 2017
    • July 2017
    • April 2017
    • February 2017
    • January 2017
    • December 2016

    Categories

    • investor
    • partner
    • Uncategorized

    Meta

    • Log in
    • Entries RSS
    • Comments RSS
    • WordPress.org
    bridgebiowp, Proudly powered by WordPress.